Author

Yucai Wang

Institutions: Mayo Clinic, Tang Du Hospital, Air Force Medical University

Observed institutions: Mayo Clinic, Tang Du Hospital, Air Force Medical University

OpenAlex ID: A5132899283

Fixed-duration pirtobrutinib plus venetoclax–rituximab versus venetoclax–rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial

2026 · Matthew S Davids, Toby A Eyre, et al. · The Lancet · 1

A Machine Learning-Based Clinical Decision Support Tool for Intertrochanteric Hip Fracture Patients to Predict Postoperative Anemia Risk: A Retrospective Cohort Study

2026 · Xinbei Dong, Qinglong Wang, et al. · Bioengineering

Abstract 4228: Validation of the CLL treatment infection model (CLL-TIM) in patients with newly diagnosed chronic lymphocytic leukemia (CLL)

2026 · Raphael Mwangi, Tait D. Shanafelt, et al. · Cancer Research

Abstract 1191: Depth of immunoparesis predicts time to first therapy in newly diagnosed monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia.

2026 · Yuan Yao, Kari G. Rabe, et al. · Cancer Research

Works count: 4

Citation count: 1

H-index: 1

I10-index: